Chyrek-Borowska S, Siergiejko Z, Michalska I, Szymański W
Kliniki Alergologii AM, Bialymstoku.
Pneumonol Alergol Pol. 1992;60(1-2):36-9.
The effect of two new quinolones, ofloxacin and ciprofloxacin and nalidixic acid on serum theophylline level in 17 asthma patients treated with methylxanthines was evaluated. Each quinolone was administered one tablet twice daily to all patients for three days. Blood samples were taken before quinolone administration and 1 h, 3h and 5 h after taking the drug on the first day. Last sample was taken 5 h after quinolone administration on the third day of therapy. The serum theophylline concentration was determined by 3 M Theo FAST test. It was found that in the patients treated with ciprofloxacin serum theophylline level in all samples was significantly higher as compared with the control sample. In the patients receiving ofloxacin the theophylline level only 1 h after receiving the drug the increase was statistical significant. Nalidixic acid had no influence on serum theophylline concentration. As these studies show, the new quinolones should be applied with great caution in patients treated with high doses of methylxanthines or in patients with decreased methylxanthines clearance. In patients with chronic obturative diseases and pulmonary infections the safer drug would appear to be ofloxacin.
评估了两种新型喹诺酮类药物(氧氟沙星、环丙沙星)及萘啶酸对17例接受甲基黄嘌呤治疗的哮喘患者血清茶碱水平的影响。每位患者每日两次服用一片每种喹诺酮类药物,共服用三天。在服用喹诺酮类药物前以及第一天服药后1小时、3小时和5小时采集血样。最后一份血样在治疗第三天服用喹诺酮类药物后5小时采集。血清茶碱浓度通过3M Theo FAST检测法测定。结果发现,与对照样本相比,接受环丙沙星治疗的患者所有样本中的血清茶碱水平均显著升高。接受氧氟沙星治疗的患者仅在服药后1小时茶碱水平升高具有统计学意义。萘啶酸对血清茶碱浓度无影响。正如这些研究所示,新型喹诺酮类药物应用于高剂量甲基黄嘌呤治疗的患者或甲基黄嘌呤清除率降低的患者时应格外谨慎。在患有慢性阻塞性疾病和肺部感染的患者中,似乎氧氟沙星是更安全的药物。